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Incidence, seasonality and comorbidity in vestibular neuritis 
 
 
Abstract 
Aims of the present study were: 1) to assess the incidence of vestibular neuritis (VN) in the adult 
population in two cities in Croatia, 2) to identify distribution of new VN cases in the different months 
and seasons by years, and 3) to identify comorbidities associated with VN. This is a prospective, 
population-based study conducted in the cities of Zagreb and Velika Gorica, Croatia in the 2011–2012 
period. All diagnoses were confirmed either with caloric test or vestibular evoked myogenic potentials 
within 7 days of symptom onset. Following clinical parameters were collected from all patients: age, 
gender, side of the lesion, month and season of symptoms onset and comorbidities. We identified 79 
new cases of VN (34 in 2011, 45 in 2012). The male to female ratio was 1.1:1. The mean age at the 
onset of the disease was 52.3 (range 20–86) years. The average annual incidence was 11.7 per 100,000 
(95% CI 7,8 - 15,6) in the 2011 period and 15.5 per 100,000 (95% CI 11,0 - 20,0) in the 2012 period. 
For both years there was no statistically significant uneven distribution in the different months or 
seasons by years. The most frequent comorbidities present in VN patients were hypertension (30.4%), 
diabetes mellitus (8.9%), hyperlipidemia (7.5%) and hypothyreosis (6.3%). Our study has shown 
higher incidence of VN than previously reported. We have found no evidence of seasonality of VN 
and significant proportion of VN patients older than 50 years who had vascular risk factors present. 
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Introduction 
Vestibular neuritis (VN) is one of the most common causes of peripheral vertigo. The vertigo in VN 
typically develops acutely, is severe for a few days, and then gradually subsides over the course of a 
few weeks.[1] Vestibular vertigo defined according to the following criteria: 1) rotational vertigo, 2) 
positional vertigo, or 3) recurrent dizziness with nausea and either oscillopsia or episodic imbalance, 
has an incidence of 15 per 100,000 persons per year.[2] An annual incidence of vestibular neuritis 
approximating 3.5 cases per 100,000 persons was reported by Sekitani and colleagues, but further 
literature on the subject is lacking.[3] 
Several facts are supporting the viral cause of VN: 1) disorder often has a viral prodrome, 3) it occurs 
in epidemics, 3) it may affect several members of the same family, and 4) it occurs more commonly in 
spring and early summer.[4] However studies investigating seasonality of VN are scarce and often 
conflicting. [5-7] 
Comorbidities associate with vestibular vertigo include self-reported depression in the past year, 
bothering tinnitus in the past 7 days, hypertension, hyperlipidemia and diabetes mellitus.[2] This 
association of vestibular vertigo with strong stroke risk factors suggest a different etiology in selected 
(older) populations. 
Aims of the present study were: 1) to assess the incidence of VN in the adult population in cities 
Zagreb and Velika Gorica, Croatia, 2) to identify distribution of new VN cases in the different months 
and seasons by years, and 3) to identify comorbidities associated with VN. 
 
Patients and methods 
This is a prospective, population-based study conducted in the cities of Zagreb and Velika Gorica in 
Croatia. According to the 2011 census an average population of these tow cities is 853.534 inhabitants. 
The emergency neurological service is provided by four hospitals in this region according to the place 
of residence, and University Hospital Center Zagreb cares for 290.306 inhabitants (34% of the 
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population) in the following communities: Medveščak, Maksimir, Novi Zagreb, Pešćenica, Trnje and 
Velika Gorica. The emergency neurological service can be reached in three ways: 1) patients are 
referred by general practitioner, 2) patients are brought to the emergency room by an ambulance, or 3) 
patients can come by themselves. In all three cases neurologist or neurological resident who is on call 
in the Emergency department of the University Hospital Center Zagreb examines the patient.  
All VN cases examined in the Emergency department were prospectively collected from the period 
2011–2012.  
Patients with vestibular neuritis nearly always report true vertigo, which is characteristically described 
as visualized spinning of the environment and the symptoms are typically severe for 1-2 days with 
gradual resolution over weeks to months.[8] Based on symptoms severity of VN and specificity of 
emergency medicine service in Croatia, it can be assumed that all VN patients will be examined in the 
emergency department in the first couple of days of clinical presentation.  
Patients older than 20 years fulfilling criteria for VN were included. The following criteria were 
applied: 1) vertigo attack lasting no more than 48 hours, 2) spontaneous horizontal-torsional 
nystagmus with the fast phase towards one side, 3) positive head-thrust test to the other side, 4) 
absence of skew deviation (assessed by Maddox rod), 5) a normal brain CT scan.[9] Patients were 
excluded if they had any other neurologic deficit; experienced hearing loss or tinnitus. If the patient 
met inclusion criteria one of the 4 neurologists with detailed knowledge and expertise in neuro-
otology, who were on call for that day, would come to the emergency department and personally 
examine the patient within 6 hours, confirming the diagnosis of VN. 
Following clinical parameters were collected from all patients: age, gender, side of the lesion, month 
and season of symptoms onset. Comorbidities of all patients were registered, as well. 
All diagnoses were confirmed either with caloric test or vestibular evoked myogenic potentials 
(VEMP) within 7 days of symptom onset. All patients underwent brain MRI, during the first three 
months from initial presentation, to exclude any brainstem and cerebellar lesions. 
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The study was approved by the Ethical Committee of the University Hospital Center Zagreb and all 
patients signed an informed consent prior to their inclusion in the study. 
Statistical Analysis. When data collection was completed, statistical calculations were made for 
annual incidence, and adjusted for gender and age on January 15th, 2013. The incidence rates are 
provided in 10-year age groups, ranging from 20 up to ≥90 years of age, for 2011 and 2012 year 
periods. Population denominator data were obtained from the 2011 national census.[10] Chi-Square 
test was used to test if there is non-random distribution and Rayleigh test was used to achieve 
information about the seasonality. To examine the association of comorbidities with VN, Pearson Chi-
Square test and Fisher's Exact test were used to determine the relationship between two categorical 
variables. Statistical analysis was performed with software IBM SPSS Statistics 20. 
 
Results 
 
Incidence. During the study period, we identified 79 new cases of VN (34 in 2011, 45 in 2012) living 
in the area of Zagreb and Velika Gorica. The male to female ratio was 1.1:1. The mean age at the onset 
of the disease was 52.3 (range 20–86) years. Altogether 66 patients performed VEMP. The VEMP 
results are shown in Table 1. Of significance is that there was a statistically significant lower 
amplitudes level in both superior (assessed with the oVEMP) and inferior (assessed with the cVEMP) 
branches of the vestibular nerve on affected side compared to the healthy side. As well 57 patients had 
performed standard caloric testing confirming the diagnosis of VN. 
The average annual incidence was 11.7 per 100,000 in the 2011 period, with a gender-specific 
incidence of 13.6 per 100,000 in men and of 10.1 per 100,000 in women. The average annual 
incidence was 15.5 per 100,000 in the 2012 period, with a gender-specific incidence of 17.4 per 
100,000 in men and of 13.9 per 100,000 in women. The annual incidence adjusted for gender and age 
for both years is presented in Tables 2 and 3. The highest incidence of VN was in the 50-69 age 
groups, 18 cases (52.9%) in 2011 period and 24 cases (53.3%) in 2012 period. 
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Seasonality. Distribution of new VN cases in the different months by years is presented in Figure 1 
and seasons by year in Figure 2. For both years there was no statistically significant uneven 
distribution in the different months (Chi-Square 7,647, p=0.745 and Chi-Square 7,533, p=0.754 for 
2011 and 2012 periods, respectively) or seasons (Chi-Square 2,235, p=0.525 and Chi-Square 1,133, 
p=0.769 for 2011 and 2012 periods, respectively) by years. The same was evident by using Rayleigh 
test: there was no evidence of seasonality for both years (Z= 0.837, p= 0.436 and Z=0.167, p= 0.847 
for 2011 and 2012 periods, respectively).  
When we divided patient into under (48 patients) or over 50 years old (31 patients) groups, we found 
no statistically significant difference in distribution of patients in the different months (Chi-Square 
5,000, p=0.931 and Chi-Square 9,000, p=0.622 for under 50 years old group and over 50 years old 
group, respectively) or seasons (Chi-Square 1,645, p=0.649 and Chi-Square 3,167, p=0.367 for under 
50 years old group and over 50 years old group, respectively). Rayleigh test showed similar 
distribution with no statistically significant evidence of seasonality (Z= 0.725, p= 0.486 and Z=0.099, 
p= 0.907 for under 50 years old group and over 50 years old group, respectively). 
Comorbidities. The most frequent comorbidities present in VN patients were hypertension (30.4%), 
diabetes mellitus (8.9%), hyperlipidemia (7.5%) and hypothyreosis (6.3%). The detailed list of all 
comorbidities present in the studied population is presented in Table 4 and 36/79 (45.5%) patients did 
not have any comorbidities. 
As more than half of the cases of VN occurred after the age of 50 (48 cases, 60.8%), we correlated the 
occurrence of four most frequent comorbidities (hypertension, diabetes mellitus, hyperlipidemia and 
hypothyreosis) with this age limit. The results have shown that hypertension and diabetes mellitus 
were statistically significant associated with the age limit of 50 years (Pearson Chi-Square 22.264, 
p<0.001 and Fisher's Exact Test 4.960, p=0.038, respectively), while there was no statistically 
significant association between hyperlipidemia and hyperthyreosis with the age limit of 50 years 
(Fisher's Exact Test 4.193, p=0.076 and Fisher's Exact Test 0.001, p=1, respectively). 
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Discussion 
Our study has shown that the incidence of VN in the study population varies from 11.7 to 15.5 per 
100000 per year. This relatively high incidence of VN is in contrast to the only incidence study 
performed in Japan, which was contrary to our study conducted by means of a questionnaire filled in 
by major neuro-otology clinics (by otolaryngologists) during 3 year period.[3] Contrary to this study, 
our study has several advantages: 1) this was a prospective, population-based study, 2) all cases were 
examined by one of 4 neurologists with detailed knowledge and expertise in neuro-otology, 3) all 
cases were confirmed either with caloric testing or VEMP, and 4) stroke was excluded by MRI as a 
possible etiology. As well, our data are more in concordance with the a population survey by validated 
neurotologic interviews carried out in Germany, which showed the 1-year incidence 14 per 100000.[2] 
The same study has also shown that of all participants with vestibular vertigo, 70% had consulted a 
doctor for their vertigo, and 80% reported severe vestibular vertigo (defined as vertigo leading to a 
medical consultation, interruption of daily activities, or sick leave). Although it is possible that we 
missed some of the cases of VN, this is unlikely due to before mentioned data in combination with 
specificities of Croatian emergency medicine system.  
Our study has also shown no evidence of seasonality for VN. It has been suggested that seasonal 
variability in VN argues viral hypothesis of VN. Several studies have suggested that a viral agent may 
be the underlying cause of VN, either by demonstrating the presence of herpes simplex virus DNA 
within vestibular nerve fibers and “Scarpa’s” ganglion or by demonstrating histologic changes within 
the vestibular nerve suggestive of viral-induced atrophy and inflammation.[11-15] On the other hand, 
an uncertain proportion of acute peripheral vestibular disorders are likely due to a vascular lesion of 
the nerve, and patients with such lesions may be at increased risk for future vascular events. [16] One 
study has suggested that age difference (50 years) plays an important role in differentiating between 
these two possible pathologies, however we were not able to confirm these results. [7] 
Contrary to this we have confirmed that patients with VN older than 50 years have comorbid 
conditions that are now vascular risk factors, possibly supporting vascular etiology of VN, at least in a 
subset of patients. Some studies have even suggested that vertebral artery hypoplasia may predispose 
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to severe VN at acute stage, through presumed regional malperfusion.[17] We have also recently 
reported that chronic white matter supratentorial lesions present on brain MRI were more frequent in 
patients with worse outcome on VEMP.[18] 
In conclusion, our study has shown higher incidence of VN than previously reported. We have found 
no evidence of seasonality of VN and significant proportion of VN patients older than 50 years who 
had vascular risk factors present. Further studies addressing possible vascular etiology of VN, in 
patients older than 50 years, are warranted. 
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Figures 
 
Figure 1. Distribution of new VN cases in the different months by years.  
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Figure 2. Distribution of new VN cases in the different seasons by year.  
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Tables 
 
Table 1. Differences in amplitudes of oVEMP and cVEMP between affected and healthy vestibular 
nerve. 
 
Variable Median N p-value 
O_H N10-P13 
amp [µV] 
6,030 66 
0,000 
O_A N10-P13 
amp [µV] 
3,600 66 
Variable Mean N p-value 
SCM_H CorAmp 
[µV] 
1,5347 66 
0,000 
SCM_AcorAmp 
[µV] 
1,1745 66 
O – ocular muscle, SCM – sternocleidomastoid muscle, A – affected side, H – healthy side, CorAmp – 
corrected amplitude  
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Table 2.  
Incidence of vestibular neuritis in 2011. 
Age 
groups 
Patients Population Incidence/100000 SE/100000; 95% CI 
Age M F All M F All M F All M F All 
20-29 2 0 2 23604 23963 47567 8,5 0,0 4,2 
6,0; -3,3 
- 20,2 
0,0 
3,0; -1,6 
- 10,0 
30-39 1 3 4 26423 27513 54136 3,8 10,9 7,4 
3,8; -3,6 
- 11,2 
6,3; -2,4 
- 23,2 
3,7; 0,1 - 
14,6 
40-49 4 2 6 23249 25169 48418 17,2 7,9 12,4 
8,6; 0,3 - 
34,1 
5,6; -3,1 
- 19,0 
5,1; 2,5 - 
22,3 
50-59 5 4 9 23196 28014 51210 21,6 14,3 17,6 
9,6; 2,7 - 
40,4 
7,1; 0,3 - 
28,3 
5,9; 6,1 - 
29,1 
60-69 5 4 9 18201 24047 42248 27,5 16,6 21,3 
12,3; 3,4 
- 51,6 
8,3; 0,3 - 
32,9 
7,1; 7,4 - 
35,2 
70-79 1 3 4 12656 18657 31313 7,9 16,1 12,8 
7,9; -7,6 
- 23,4 
9,3; -2,1 
- 34,3 
6,4; 0,3 - 
25,3 
80-89 0 0 0 4603 9684 14287 0,0 0,0 0,0 0,0 0,0 0,0 
90+ 0 0 0 351 976 1327 0,0 0,0 0,0 0,0 0,0 0,0 
TOTAL 18 16 34 132283 158023 290306 13,6 10,1 11,7 
3,2; 7,3 - 
19,9 
2,5; 5,2 - 
15,1 
2,0; 7,8 - 
15,6 
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Table 3. Incidence of vestibular neuritis in 2012. 
Age 
groups 
Patients Population Incidence/100000 SE/100000; 95% CI 
Age M F All M F All M F All M F All 
20-29 2 2 4 23604 23963 47567 8,5 8,3 8,4 
6,0; -3,3 
- 20,2 
5,9; -3,2 
- 19,9 
4,2; 0,2 - 
16,7 
30-39 2 3 5 26423 27513 54136 7,6 10,9 9,2 
5,4; -2,9 
- 18,1 
6,3; -1,4 
- 23,2 
4,1; 1,1 - 
17,3 
40-49 4 4 8 23249 25169 48418 17,2 15,9 16,5 
8,6; 0,3 - 
34,1 
7,9; 0,3 - 
31,5 
5,8; 5,1 - 
28,0 
50-59 12 6 18 23196 28014 51210 51,7 21,4 35,1 
14,9; 
22,5 - 
81,0 
8,7; 4,3 - 
38,6 
8,3; 18,9 
- 51,4 
60-69 1 5 6 18201 24047 42248 5,5 20,8 14,2 
5,5; -5,3 
- 16,3 
9,3; 2,6 - 
39,0 
5,8; 2,8 - 
25,6 
70-79 1 2 3 12656 18657 31313 7,9 10,7 9,6 
7,9; -4,1 
- 23,4 
7,6; -4,1 
- 25,6 
5,5; -1,3 
- 20,4 
80-89 1 0 1 4603 9684 14287 21,7 0,0 7,0 
21,7; 
20,9 - 
64,3 
0,0 
7,0; -6,7 
- 20,7 
90+ 0 0 0 351 976 1327 0,0 0,0 0,0 0,0 0,0 0,0 
TOTAL 23 22 45 132283 158023 290306 17,4 13,9 15,5 
3,6; 10,3 
- 24,5 
3,0; 8,1 - 
19,7 
2,3; 11,0 
- 20,0 
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Table 4. Comorbidities of patients with vestibular neuritis 
Disease Number of patients Percentage 
Hypertension 24 30.4% 
Diabetes mellitus 7 8.9% 
Hyperlipidemia 6 7.5% 
Hypothyreosis 5 6.3% 
Coronary heart disease 4 5.1% 
Peptic ulcer 3 3.8% 
Nephrolithiasis 3 3.8% 
Glaucoma 2 2.5% 
Alcoholism 2 2.5% 
Prostate hypertrophy 2 2.5% 
Chronic sinusitis 2 2.5% 
Thalassemia 1 1.3% 
Polycitemia rubra vera 1 1.3% 
Breast cancer 1 1.3% 
Gonarthrosis 1 1.3% 
Chronic obstructive lung disease 1 1.3% 
Angina pectoris 1 1.3% 
Chronic pancreatitis 1 1.3% 
Hyperuricemia 1 1.3% 
Mitral valve prolapse 1 1.3% 
Post traumatic stress disorder 1 1.3% 
Gastritis 1 1.3% 
Thyroid carcinoma 1 1.3% 
Headache 1 1.3% 
Seizures 1 1.3% 
Stroke 1 1.3% 
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Hepatitis C1 1 1.3% 
Sinus tachycarida 1 1.3% 
 
 
 
 
 
